Together with the absence of symptoms associated with IGF-1-mediated effects such as fluid retention, tissue edema, or impaired glucose tolerance, these results demonstrate that AOD-9604 does not activate the growth hormone/IGF-1 pathway and therefore functions through an entirely appetite-independent mechanism
The reagents in different kits cannot be mixed with each other
This Product is not intended to diagnose, treat, cure or prevent any disease
(2018, March 12)
Expectation Setting: Discussion of realistic outcomes, duration of treatment, and potential side effects
However, it is not FDA-approved for human use and cannot legally be marketed as a drug, supplement, or for human consumption